BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

738 related articles for article (PubMed ID: 19638944)

  • 1. Plasma vasopressin and V2 receptor in the endolymphatic sac in patients with delayed endolymphatic hydrops.
    Kitahara T; Maekawa C; Kizawa K; Horii A; Doi K
    Otol Neurotol; 2009 Sep; 30(6):812-9. PubMed ID: 19638944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meniere's attacks occur in the inner ear with excessive vasopressin type-2 receptors.
    Kitahara T; Doi K; Maekawa C; Kizawa K; Horii A; Kubo T; Kiyama H
    J Neuroendocrinol; 2008 Dec; 20(12):1295-300. PubMed ID: 19094077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and translocation of aquaporin-2 in the endolymphatic sac in patients with Meniere's disease.
    Maekawa C; Kitahara T; Kizawa K; Okazaki S; Kamakura T; Horii A; Imai T; Doi K; Inohara H; Kiyama H
    J Neuroendocrinol; 2010 Nov; 22(11):1157-64. PubMed ID: 20722976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endolymphatic sac tumor with overexpression of V2 receptor mRNA and inner ear hydrops.
    Kitahara T; Maekawa C; Kizawa K; Kamakura T; Horii A; Inohara H
    Acta Otolaryngol; 2011 Sep; 131(9):951-7. PubMed ID: 21574774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Delayed endolymphatic hydrops].
    Giannoni B; Pagnini P; Vannucchi P
    Acta Otorhinolaryngol Ital; 1998 Aug; 18(4 Suppl 59):66-70. PubMed ID: 10205936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed endolymphatic hydrops: study and review of clinical implications and surgical treatment.
    Huang TS; Lin CC
    Ear Nose Throat J; 2001 Feb; 80(2):76-8, 81-2, 84 passim. PubMed ID: 11233350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed endolymphatic hydrops as a clinical entity.
    Kamei T
    Int Tinnitus J; 2004; 10(2):137-43. PubMed ID: 15732511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance imaging of guinea pig cochlea after vasopressin-induced or surgically induced endolymphatic hydrops.
    Marshall AF; Jewells VL; Kranz P; Lee YZ; Lin W; Zdanski CJ
    Otolaryngol Head Neck Surg; 2010 Feb; 142(2):260-5. PubMed ID: 20115985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ménière's Disease Pathophysiology: Endolymphatic Sac Immunohistochemical Study of Aquaporin-2, V2R Vasopressin Receptor, NKCC2, and TRPV4.
    Asmar MH; Gaboury L; Saliba I
    Otolaryngol Head Neck Surg; 2018 Apr; 158(4):721-728. PubMed ID: 29436285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anatomical variation of inner ear may be a predisposing factor for unilateral Ménière's disease rather than for ipsilateral delayed endolymphatic hydrops.
    Lei P; Leng Y; Li J; Zhou R; Liu B
    Eur Radiol; 2022 May; 32(5):3553-3564. PubMed ID: 34978581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies against inner ear proteins in patients with delayed endolymphatic hydrops and unilateral juvenile deafness.
    Suzuki M; Hanamitsu M; Kitanishi T; Kohzaki H; Kitano H
    Acta Otolaryngol; 2006 Feb; 126(2):117-21. PubMed ID: 16428186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of vasopressin on gene expression in rat inner ear.
    Gu FM; Han HL; Zhang LS
    Hear Res; 2006 Dec; 222(1-2):70-8. PubMed ID: 17070001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Delayed endolymphatic hydrops: an analysis of 12 cases].
    Casani A; Fattori B; Berrettini S; De Ciccio M; Vannucci G; Ghilardi PL
    Acta Otorhinolaryngol Ital; 1993; 13(4):297-303. PubMed ID: 8135101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of labyrinthectomy in the treatment of Menière's disease and delayed endolymphatic hydrops.
    Yazdi AK; Rutka J
    J Otolaryngol; 1996 Feb; 25(1):26-31. PubMed ID: 8816106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endolymphatic hydrops in asymptomatic ears in unilateral Ménière's disease.
    Friedrichs I; Thornton AR
    Laryngoscope; 2001 May; 111(5):857-60. PubMed ID: 11359166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preceding profound deafness and co-factors promote development of endolymphatic hydrops in preliminary patients with delayed endolymphatic hydrops.
    Fukushima M; Ito R; Miyaguchi S; Hirai T; Otami Y; Akahani S; Inohara H; Takeda N
    Acta Otolaryngol; 2016 Dec; 136(12):1304-1308. PubMed ID: 27383063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endolymphatic sac decompression as a treatment for Meniere's disease.
    Durland WF; Pyle GM; Connor NP
    Laryngoscope; 2005 Aug; 115(8):1454-7. PubMed ID: 16094123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma antidiuretic hormone in cases with the early onset of profound unilateral deafness.
    Takeda T; Kakigi A; Nishioka R; Taguchi D; Nishimura M
    Auris Nasus Larynx; 2008 Dec; 35(4):493-9. PubMed ID: 18329206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome-based assessment of endolymphatic sac decompression for Ménière's disease using the Ménière's disease outcome questionnaire: a review of 90 patients.
    Convert C; Franco-Vidal V; Bebear JP; Darrouzet V
    Otol Neurotol; 2006 Aug; 27(5):687-96. PubMed ID: 16868517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormonal aspects of Ménière's disease on the basis of clinical and experimental studies.
    Takeda T; Takeda S; Kakigi A; Okada T; Nishioka R; Taguchi D; Nishimura M; Nakatani H
    ORL J Otorhinolaryngol Relat Spec; 2010; 71 Suppl 1():1-9. PubMed ID: 20185943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.